HSA approves molnupiravir
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Most Read
1. Chronic diseases to drive MRI systems market 2031 expansion to $9.68b 2. How can hospitals maintain care during cyber disruptions? 3. China healthcare sector hit by regulation, biotech uncertainty 4. Jardine Matheson to buy Australian medical firm for $2.4b 5. Singapore heart centre deploys photo-counting CT for complex cardiac casesResource Center
Read Here
Advertise
Sign Up
Event News
It will feature forums, demos, and business matching activities.
Commentary
Why health system research deserves more attention
How the healthcare ecosystem is responding to change the trajectory of myopia